| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.084 | 0.1 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.045 | 0.1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.053 | 0.1 |